Literature DB >> 1899559

Tumor necrosis factor alone does not explain the lethal effect of lipopolysaccharide.

L Sánchez-Cantú1, H N Rode, T J Yun, N V Christou.   

Abstract

Lethality and tumor necrosis factor production induced by different types of lipopolysaccharide were studied in naive (non-primed) rats during the late phase of endotoxin tolerance. The correlation with antilipopolysaccharide antibodies was also analyzed. No correlation was found between tumor necrosis factor levels and lipopolysaccharide-induced mortality in naive animals. Low-toxicity lipopolysaccharide preparations induced levels of tumor necrosis factor similar to those induced with more toxic types of lipopolysaccharide. Late tolerance was associated with progressively lower levels of lipopolysaccharide-induced tumor necrosis factor and increasing titers of antilipopolysaccharide antibodies after repeated injections of homologous lipopolysaccharide. During late endotonxin tolerance, a direct correlation between the lipopolysaccharide dose and peak tumor necrosis factor serum levels was found. We conclude that since tumor necrosis factor serum levels do not correlate with mortality, tumor necrosis factor alone cannot explain the lethal effect of lipopolysaccharide.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1899559     DOI: 10.1001/archsurg.1991.01410260121017

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  5 in total

1.  A synthetic lipopolysaccharide-binding peptide based on the neutrophil-derived protein CAP37 prevents endotoxin-induced responses in conscious rats.

Authors:  D J Brackett; M R Lerner; M A Lacquement; R He; H A Pereira
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

2.  In vivo cytokine response to Escherichia coli alpha-hemolysin determined with genetically engineered hemolytic and nonhemolytic E. coli variants.

Authors:  A K May; R G Sawyer; T Gleason; A Whitworth; T L Pruett
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

3.  Mechanisms involved in the pathogenesis of sepsis are not necessarily reflected by in vitro cell activation studies.

Authors:  C R Amura; R Silverstein; D C Morrison
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

4.  Immunological priming attenuates the in vivo pathophysiological response to lipopolysaccharide. Comparison of cytokine production, tissue injury, and lethality in complete Freund's adjuvant-primed mice and in unprimed mice.

Authors:  L E DeForge; E Takeuchi; D T Nguyen; D G Remick
Journal:  Am J Pathol       Date:  1994-03       Impact factor: 4.307

5.  Identification of murine protective epitopes on the Porphyromonas gingivalis fimbrillin molecule.

Authors:  M Deslauriers; S Haque; P M Flood
Journal:  Infect Immun       Date:  1996-02       Impact factor: 3.441

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.